Comment on "Correlation of L-asp Activity, Anti-L-asp Antibody, asn and gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL"

对“L-天冬氨酸活性、抗L-天冬氨酸抗体、天冬酰胺和谷氨酰胺与PEG-天冬氨酸治疗方案治疗的儿童急性淋巴细胞白血病不良事件（尤其是过敏反应风险）的相关性”的评论